A decision by a health watchdog to reject a life-prolonging prostrate cancer drug from National Health Service (NHS) has come under severe criticism from cancer charities and patients.
244117 items (244117 unread) in 108 feeds
NewsPopular
(136336 unread)
DoWireFeeds
(91068 unread)
CitizenMedia
(10309 unread)
Radio
(6404 unread)
A decision by a health watchdog to reject a life-prolonging prostrate cancer drug from National Health Service (NHS) has come under severe criticism from cancer charities and patients.